The subjects likely to surface at Tuesday's Senate hearings -- high drug prices and profits, limited price transparency, aggressive marketing, alleged patent abuse and mediocre, "me-too" drugs -- are identical to the issues senators investigated decades ago.
from CNN.com - RSS Channel - Health https://ift.tt/2H1kFRj
No comments:
Post a Comment